CompletedNot Applicable

Impact of COVID-19 on Sinus Augmentation Surgery

Egypt24 participantsStarted 2023-03-30

Plain-language summary

The risk of Schneiderian membrane perforation and the postoperative complications of the sinus floor elevation surgery were evaluated for patients with and without history of COVID-19 infection.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 4 mm or less residual alveolar bone height * Age more than 18 years * Highly motivated patients Exclusion Criteria: * Patients who suffer from any systemic disease * sinus pathosis other than sinusitis induced covid 19 * Patients under any medication that may interfere with the normal bone healing

What they're measuring

Sinus membrane perforation

Timeframe: Duration sinus lift

Trial details

NCT IDNCT05960136

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-07-15

View on ClinicalTrials.gov More Bone Loss trials